CryoPen, Inc., today announced that its new GY2 Cryosurgical System has been cleared by the Food and Drug Administration for use in gynecology. This new treatment will help medical professionals ...
Ablation therapy is appropriate for lesions that involve less than 75% of the cervix, do not extend into the endocervical canal or onto the vagina, and are not suggestive of invasive cancer. 3 This ...
HONOLULU — Thermal ablation delivered via a portable, battery-powered, low-cost device is at least as effective as standard cryotherapy and loop electrosurgical excision (LLETZ) at treating ...